Taysha Gene Therapies (TSHA) EPS (Diluted) (2021 - 2026)

Taysha Gene Therapies (TSHA) EPS (Diluted) (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	4.31
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	12.23
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	7.33
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-3.06
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.16
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	0.00
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.15
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.19
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.06
10	Taysha Gene Therapies	1.94 Bn	1.94 Bn	-	-0.13

Download Data